CVAC – curevac n.v. - ordinary shares (US:NASDAQ)

News

CureVac N.V. (CVAC): A Bull Case Theory [Yahoo! Finance]
CureVac (NASDAQ:CVAC) was downgraded by analysts at Weiss Ratings from a "hold (c-)" rating to a "sell (d-)" rating.
CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
BioNTech's exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3 [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com